Keyphrases
Mesenchymal Stem Cells
100%
Exosomes
43%
Preeclampsia
41%
Gelatin
29%
Small Extracellular Vesicles
25%
Salmon Gelatin
24%
Mesenchymal Stromal Cells
23%
Pregnant Women
20%
Endometrial Stem Cells
20%
COVID-19
18%
T Helper 17 (Th17)
17%
Extracellular Vesicles
17%
Cell-based
17%
MicroRNA
16%
Mitochondria
15%
Ischemia-reperfusion Injury
14%
T Cells
14%
Astrocytes
14%
During Pregnancy
14%
Voice Therapy
14%
Semi-occluded Vocal Tract Exercises (SOVTE)
13%
Biomaterials
13%
Fluoxetine
13%
Inducible Nitric Oxide Synthase
13%
First Trimester
13%
Macrophages
12%
Human Mesenchymal Stem Cells (hMSCs)
12%
Fetus
12%
Inflammation
12%
Gestational Diabetes Mellitus
12%
Cell Therapy
12%
Placenta
11%
Water Resistance Therapy
11%
Maternal Plasma
11%
Chronic Kidney Disease
11%
Selective Intrauterine Growth Restriction (sIUGR)
11%
Chitosan-gelatin
11%
Vocal Fatigue
10%
Stem Cells
10%
Ischemia Injury
10%
Kidney
10%
Biopolymers
9%
Tissue Engineering
9%
Gelatin Film
9%
Vocal Tract
9%
Physiologic
8%
Voice Rehabilitation
8%
Hypoxia
8%
Experimental Autoimmune Encephalomyelitis
8%
Toll-like
8%
Regulatory T (Treg) Cells
8%
Bacterial Cellulose
8%
Interleukin-33 (IL-33)
8%
Female Fertility
8%
Dysphonia
8%
Neural Stem Cells
8%
Quantitative PCR
8%
Reperfusion
8%
Glassy State
8%
Vocal
8%
Chile
7%
Glycerol
7%
Cell-derived
7%
Angiogenesis
7%
Pregnancy Trimester
7%
Speech-language Pathologists
7%
Mitochondrial Transfer
7%
Interleukin-17 (IL-17)
7%
Postsynaptic Density Protein 95 (PSD-95)
7%
Telepractice
7%
Stem Cell Therapy
7%
Ischemia
7%
Acute Respiratory Distress Syndrome
7%
Cell-mediated
7%
Therapeutic Properties
7%
Stem Cell-derived
6%
Edible Film
6%
Regulatory T Cells
6%
Clinical Application
6%
Central Nervous System
6%
Gestational Diabetes
6%
Gestational Age
6%
Rat Model
6%
Endothelial Cells
6%
Nuclear Factor of Activated T-cells 5
6%
Oxidative Stress
6%
Menstrual Blood
6%
Neurogenesis
6%
Systemic Lupus Erythematosus
6%
Randomized Controlled Trial
6%
Placental Exosomes
6%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
6%
Peroxisome Proliferator-activated Receptor
6%
CD4+
6%
Directed Evolution
6%
Chilean
6%
Mesenchymal Stem Cell Therapy
6%
Preterm Birth
6%
Glass Transition Temperature
6%
Blueberry
6%
Medicine and Dentistry
Mesenchymal Stem Cell
36%
Pre-Eclampsia
29%
Disease
22%
Stem Cell
19%
First Trimester Pregnancy
17%
Vocal Tract
16%
Gestational Diabetes
14%
Voice Therapy
13%
Exosome
13%
COVID-19
12%
Speech Production
10%
Cell Therapy
10%
Ischemia
9%
Biological Marker
9%
Therapy Resistance
9%
Intrauterine Growth Retardation
8%
Dysphonia
8%
Female Fertility
8%
Neonatal Infant
7%
Messenger RNA
7%
Premature Labor
7%
Peritoneal Dialysis
7%
Randomized Controlled Trial
7%
Placenta
7%
microRNA
7%
Trophoblast
7%
Phonation
7%
Acute Kidney Injury
7%
Chronic Kidney Disease
6%
Fetus Growth
6%
Pregnancy
6%
Reperfusion Injury
6%
Systemic Lupus Erythematosus
6%
In Vitro
6%
Mitochondrion
6%
Fibroblast Growth Factor 23
6%
Speech Rehabilitation
6%
Ovarian Cancer
6%
Meta-Analysis
6%
Gestational Age
6%
Pathologist
6%
Infection
5%
Angiogenesis
5%
Hypoxia
5%
Oxidative Stress
5%
Injury
5%
Telepractice
5%
Uterine Artery
5%
Vocal Folds
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Osteoarthropathy
5%
Quality of Life
5%